← Back to headlines
New Pancreatic Cancer Pill Shows Promise in Early Trials
Early trial results for a new daily pill, daraxonrasib, are showing significant promise in treating advanced pancreatic cancer in patients with RAS mutations.
18 May, 11:00 — 18 May, 11:00
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Giant Asteroid to Pass Close to Earth, Closer Than Moon's Quarter Distance
14m ago
New research reveals medieval mercury treatment for leprosy
28m ago
Climate Change Linked to Increased Heart Attack and Stroke Risk
33m ago